Bluejay Therapeutics, a drug developer focused on serious viral and liver diseases, is considering a US initial public offering, according to people familiar with the matter.

As far as MLB prospects go, Toronto Blue Jays utility man Alan Roden isn't exactly young. Now 25 years old and some three ...

As far as MLB prospects go, Blue Jays utility man Alan Roden isn't exactly young. But he might have the most unique dreams of ...

Athlon Sports dissects everything you need to know about the club ahead of the upcoming Major League Baseball season.

Alan Roden has become a name to watch in the Toronto Blue Jays' farm system after ending his 2024 season strong and impressing early in Spring Training this year. The young outfielder, a third ...

it’s the sudden change in the behavior of blue jays. Following a quiet summer of nesting and raising young, the newly independent parents, and their maturing offspring, turn their attention to ...

Toronto Blue Jays starting pitcher Chris Bassitt is the team's honourary bat boy after coming in last place in their fantasy football league, joining former member of the Blue Jays Tim Mayza who ...

The Toronto Blue Jays are heading into a critical 2025 season relying on a veteran-laden pitching staff, for better or worse. Yahoo Sports' Jake Mintz and Jordan Shusterman have sifted through ...

The Toronto Blue Jays opened the Grapefruit League season on Saturday afternoon against the New York Yankees, but the best story wasn't what was happening between the lines, it was what was ...

Blue Jays could ship $33 million All-Star to Brewers on 1 condition Aaliyan Mohammed If the season slips away they will likely become sellers, indicating an end of Bo Bichette and Vladimir ...

The Blue Jays once again have one of the best rosters in the league, led by superstar infielders Vladimir Guerrero Jr. and Bo Bichette. Vladdy Jr. hit 30 home runs and produced a .323 batting ...

It has been an eventful MLB offseason for the Toronto Blue Jays. While the biggest story was Vladimir Guerrero Jr. and the Blue Jays' inability to extend him, there were some positive developments ...